• AIDS 2024 | WHO-Recommended Triple HIV Testing Algorithm Significantly Improves Diagnostic Accuracy

    In 2023, the World Health Organization (WHO) recommended that countries with low HIV prevalence adopt a triple testing approach to confirm HIV-positive diagnoses. Specifically, WHO advises countries with an HIV prevalence below 5% to use three consecutive tests to ensure a 99% diagnostic accuracy. The proportion of positive HIV tests in a population can impact…

  • AIDS Dialogue | Acute HIV Infection Detection: A Critical Battle to Block Transmission and Improve Prognosis

    Early detection and treatment of HIV play a crucial role in AIDS prevention and control. A critical battlefield is emerging with increasing importance—the timely detection of acute HIV infection (AHI). AHI refers to the period from the entry of the HIV virus into the body until antibodies become detectable, typically occurring within a few weeks…

  • AIDS Interview | High-Risk Factors and Strategies for HIV Vertical Transmission

    On the global journey to eliminate HIV infections among children, different countries and regions face distinctly different challenges. Recently, at the AIDS2024 conference, Dr. Kira Elsbernd from the University of Munich in Germany delivered a special report on the risk factors involved in HIV vertical transmission and was interviewed by Infectious Diseases Frontier(IIDF). Dr. Elsbernd…

  • AIDS Exclusive Interview | Caring for Children with HIV: Advances in Pediatric HIV Care

    Pediatric care and treatment for children with HIV infection have always been a critical component in the global fight against AIDS. Recently, at the AIDS2024 conference, Dr. Anna Turkova from University College London shared her insights with Infectious Diseases Frontier(IIDF) on the breakthrough advancements in pediatric HIV care. She highlighted that the detection and diagnosis…

  • Dr. Rumi: Analysis of Effective Intervention Methods for MAFLD and HCC

    Recently, Combined GIHep&SHC 2024 was successfully held in Singapore. Experts in the field of liver disease from around the world gathered together to discuss the latest developments, challenges, and opportunities in liver disease. Reporters from Hepatology Digest rushed to the scene and conducted interviews with multiple experts. During the interview, Dr. Md Shofequnnabi Rumi, Assistant…

  • Type 2 Diabetes as a Significant Factor Increasing Mortality After Liver Transplantation

    At the recently concluded American Diabetes Association (ADA) Annual Meeting, an oral presentation highlighted that liver transplant patients with type 2 diabetes (T2DM) have significantly higher postoperative mortality rates compared to those without diabetes. This finding holds substantial importance for improving liver transplant success rates and enhancing long-term survival outcomes for patients.

  • Dr. Daniel Huang Qingyao: Exploring the Challenges and Future Trends of Fatty Liver in Asia

    he Combined GlHep&SHC 2024 Conference will be held in Singapore from July 25th to 28th, 2024. Dr. Daniel Huang Qingyao from the National University Hospital of Singapore gave multiple presentations at the meeting. Hepatology Digest invited Dr. Daniel Huang Qingyao to share on metabolic associated fatty liver disease (MAFLD), liver disease examination methods, and other…

  • 2024 CUDA丨Dr. Hao Zeng: Optimizing Treatment Strategies for Advanced Renal Cell Carcinoma, Exploring New Possibilities for Greater Patient Benefit

    In recent years, with the advancements in targeted therapy and immunotherapy, significant progress has been made in the treatment of advanced renal cell carcinoma (RCC). Several large-scale phase III clinical trials involving targeted and immunotherapy combinations have been successful, marking the beginning of a new era in first-line treatment for advanced RCC. Following the successful…